Metraipolis › archive › dc_02c588e7cc10
Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42795015
- DOI
- 10.3390/cancers18183049
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:28:36.533Z
- SHA-256 of the archived text
1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38- Stable URL of this page
https://metraipolis.com/documento/dc_02c588e7cc10
How to cite
Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015 — Europe PMC (en), https://europepmc.org/article/MED/42795015 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02c588e7cc10 (Metraipolis archive dc_02c588e7cc10, sha256 1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38)
BibTeX
@misc{dc02c588e7cc10,
title = {Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting — Europe PMC PMID:42795015},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42795015},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02c588e7cc10; sha256 1ebc94ba770b09239bdbf8b56b38b649f7d290b8f046679916c26489223d5a38},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795015. Agents can read the archived copy with the MCP tool read_document.